Treatment of Bifurcated Coronary Lesions With Cypher™-Stent
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00288535|
Recruitment Status : Unknown
Verified March 2005 by University Heart Center Freiburg - Bad Krozingen.
Recruitment status was: Recruiting
First Posted : February 8, 2006
Last Update Posted : September 18, 2007
|Condition or disease||Intervention/treatment||Phase|
|Coronary Artery Disease||Procedure: PCI of bifurcated coronary lesions using sirolimus coated stents in modified T-Stenting -Technique||Phase 4|
Bifurcations involving a significant side branch (SB diameter ≥ 2.25 mm) occur in approximately 15-20% of all coronary lesions considered for percutaneous intervention. If a side branch (SB) subtends significant myocardium, failure to preserve SB vessel patency can lead to complications such as myocardial infarction or persistent chest pain despite full patency of the main branch.
Bifurcation lesions are inherently complex and interventional treatment remains a challenging problem for physicians.
The optimal technique for stenting bifurcated lesions is still unknown. Several dual vessel stenting techniques have been described in the literature, such as "T", "V", "Y", "Culotte" and "Crush" procedures. However, most studies of bifurcation stenting have found that optimal long-term results are obtained by stenting the main vessel and then performing plain balloon angioplasty of the side branch ("kissing balloon"-technique). Nevertheless, occlusion or reduced flow of the SB are frequent after stenting of the MB. Therefore, the SB is stented in approximately 50% of procedures even if PTCA alone was intended.
Compared with plain dilatation of side branch, the placement of Cypher-Stent in side branch using modified T-stenting technique will reduce "in-segment percent diameter stenosis" of the side branch at 9 months post procedure as measured by quantitative coronary angiography.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||200 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Prospective, Randomized, Single-Center Evaluation of the Cypher™ Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions|
|Study Start Date :||March 2005|
|Study Completion Date :||February 2007|
- In-segment percent diameter stenosis of the side branch at 9 months post procedure as measured by quantitative coronary angiography.
- Freedom from Major Adverse Cardiac Events (MACE)at 30 days, 6 and 12 months
- Angiographic binary restenosis (≥ 50% diameter stenosis) in the main and side branch at 9 months post procedure.
- Target Lesion Revascularization (TLR) at 12 months post procedure.
- Device success during PCI
- Post-procedure thrombotic stent occlusion at 12 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00288535
|Contact: Miroslaw Ferenc, Dr.||0049 7633 4020||Miroslaw.Ferenc@herzzentrum.de|
|Contact: Franz-Josef Neumann, Prof. Dr.||0049 7633 4020||Franz-Josef.Neumann@herzzentrum.de|
|Principal Investigator:||Miroslaw FERENC, Dr.||Haert Center Bad Krozingen; Germany|
|Study Director:||Franz-Josef Neumann, Prof. Dr.||Heart Center Bad Krozingen, Germany|